Skip to content
VuFind
  • Login
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
Advanced
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Save to List
  • Permanent link
Cover Image

Saved in:
Bibliographic Details
Main Authors: Satoru Kakizaki, Tadashi Ikegami, Takeshi Hatanaka, Yuhei Suzuki, Takashi Hoshino, Atsushi Naganuma, Daichi Takizawa, Hirotaka Arai, Takashi Ueno, Keisuke Iizuka, Takahiro Arisaka, Yuichi Majima, Makoto Iijima, Shigeo Tano, Toshiyuki Tahara, Masahiro Araki, Toshiro Kamoshida, Yoshinari Takaoka, Hidekazu Kurata, Yukimura Fukaya, Kuniaki Fukuda, Atsuko Soeda, Takayoshi Suga, Shuichi Saito, Toru Fukuchi, Satoshi Takakusagi, Hitoshi Takagi, Katsuhiko Horiuchi, Yuki Kanayama, Toshiya Ohtake, Hiroki Tojima, Yuichi Yamazaki, Shunji Watanabe, Kouichi Miura, Naoki Morimoto
Format: Artículo Open Access
Published: Wiley 2026
Subjects:
Hepatology Research
Online Access:https://onlinelibrary.wiley.com/doi/10.1111/hepr.70172
Tags: Add Tag
No Tags, Be the first to tag this record!
  • Holdings
  • Description
  • Table of Contents
  • Comments
  • Similar Items
  • Staff View

Internet

https://onlinelibrary.wiley.com/doi/10.1111/hepr.70172

Similar Items

  • Clinical Utility of the aMAP Risk Score for Predicting the Recurrence of Hepatic Encephalopathy After Rifaximin Treatment in Patients With Liver Cirrhosis: A Retrospective Cohort Study
    by: Satoshi Takakusagi, et al.
    Published: (2026)
  • Sofosbuvir/Velpatasvir/Voxilaprevir Versus Sofosbuvir/Velpatasvir Plus Ribavirin in Patients With Hepatitis C Virus Genotype 3b and Compensated Cirrhosis: A Multicentre Randomized Controlled Trial
    by: Rui Huang, et al.
    Published: (2025)
  • Response to Letter to ‘Serum CRP in Durvalumab–Tremelimumab‐Treated HCC : Expanding the Inflammatory Narrative’
    by: Takeshi Hatanaka, et al.
    Published: (2025)
  • Response to Letter to ‘Serum CRP in Durvalumab‐Tremelimumab‐Treated HCC : Expanding the Inflammatory Narrative’
    by: Takeshi Hatanaka, et al.
    Published: (2025)
  • Successful Retreatment of Glecaprevir‐Pibrentasvir for Hepatitis C Virus Genotype 2a Infection in Patient Whose Cirrhosis Improved From Decompensation to Compensation After Sofosbuvir–Velpatasvir Therapy
    by: Tatsuo Kanda, et al.
    Published: (2025)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs